Spasticity – Spa Mouse Model 

Study novel interventions to improve physical performance in patients affected by muscular Spasticity using the Spa mouse model

Home » Neurology Research Models and Services  » Neuromuscular Disease – Spasticity

Spasticity refers to stiff or rigid skeletal muscle tone which affects skeletal muscle contraction, movement, speech and other daily activities. Spasticity is a symptom that is present in several diseases that affect the neuromuscular system, namely Cerebral palsy, and Amyothropic Lateral Sclerosis (ALS). Furthermore, spasticity can also arise due to trauma, such as spinal cord injury (SCI) or stroke. 

As such, spasticity can be modelled using InnoSer’s Spa mouse model which is characterised by a spontaneous spasticity-associated mutation, resulting in early-onset hypertonia. The Spa mouse presents symptoms of spasticity at 2 weeks of age and can reach adult age, making this mouse model highly suitable for therapies aimed to improve skeletal muscle function across multiple conditions or diseases. 

Take advantage of InnoSer’s expertise in modelling neuromuscular disease pathology, flexibility and collaborative approach for your research. Our in-house neurology experts are happy to help guide your decision on study design fit for your current research goals. 

Spa mouse model key characteristics:

  • Spa mice have a hereditary spastic mutation (B6.Cg-Glrbspa/J).
  • Spastic mice display a series of abnormalities, such, including abnormal gait, impaired hind limb motor function, reduced physical activity.
  • Spa mice show skeletal muscle morphology alterations (i.e., muscle mass decrease along with a decrease in the cross-sectional area of myofibers).
  • Model is extensively characterised (published together with Rivares et al, 2020).

Find the right model for you.

Compare our model capabilities and discover which of our neurology platforms suits your research needs

Belgian based preclinical neurology CRO mouse models

Key readouts in the Spa mouse model

Test the efficacy of your treatments with the following commonly used behavioral tests:

Example data featuring the Spa mouse model

Related neuromuscular disease model options

Neurology Platform Overview

Highly relevant neurology models to facilitate preclinical drug development.

Charcot Marie Tooth Disease Type 1A C3-PMP22 Mouse Model

InnoSer offers a fee-for-service C-3PMP22 model to research novel therapies against Charcot Marie Tooth Type 1A. 

Duchenne Muscular Dystrophy (DMD) Mouse Model

Perform behavioural research studies to investigate your novel and innovative targeted DMD therapies.  

AAALAC Accreditation

InnoSer has earned the AAALAC accreditation, demonstrating our commitment to responsible animal care and use. AAALAC International is a nonprofit organization that promotes the humane treatment of animals in science through voluntary accreditation and assessment programs. Our accreditation is valid for three years, incl. 2023. Read more about the AAALAC accreditation programme here.

AAALAC logo

Animal Welfare

The 3Rs impact everything from policy and regulatory change to the development and uptake of new technologies and approaches. This is why Innoser has ongoing commitment and monitoring of these processes. The steps we practice maximize our ability to replace, reduce and refine animal involvement and facilitate our commitment to these principles when it comes to research and drug development.

Need more information?

If you have any questions about how we can help accelerate your research,

then let us know